Diisononyl phthalate (DINP), a widely used plasticizer, has been evaluated in two chronic studies in rats and one in mice. In the early 1980s, Exxon found no carcinogenic potential at the estimated maximum tolerated dose (MTD) of 0.6% (307 mg/kg/ day for male rats) administered in the diet of rats for 2 years. A recent study conducted at dietary levels up to 1.2% DINP (733 mg/kg/d for male rats) reported kidney tumors in male rats at the high treatment level, but not in female rats nor mice of either sex. Because these tumors occurred only in male rats, and only at high doses, the male rat-specific alpha 2u-globulin (␣2UG) mechanism of action was investigated. Technological advances in immunohistochemical staining and computerized image analysis techniques permitted measuring the accumulation of ␣2UG in archived kidneys from the earlier Exxon study. Using archived tissue obtained at the 12-month interim sacrifice, we identified a dose-dependent accumulation of ␣2UG in specific regions of male rat kidneys only. An increase in cell proliferation was confirmed by immunohistochemical detection of proliferating-cell nuclear antigen (PCNA) and was confined to the areas of ␣2UG accumulation. H and E-stained sections revealed tubular epithelial hypertrophy and regeneration, consistent with the immunohistopathology findings. These findings are consistent with the ␣2UG mechanism of tumorigenesis, which is not regarded as relevant for humans. Thus, exposure to DINP produced a dose-dependent ␣2UG accumulation in male rat kidneys, significant at a dietary level of 0.6% and a likely mechanism for the kidney tumors seen only in male rats administered higher dietary levels of DINP.
Diisononyl phthalate (DINP) is an isomeric mixture of diesters of ortho-phthalic acid and primary aliphatic branchedchain alcohols, predominantly in the C9 range. DINP is used principally to add flexibility to a variety of materials including polyvinyl chloride (Cadogan, 1992) .
DINP was evaluated in subchronic and chronic studies in rats in the early 1980s; no toxicologically important renal effects were found at dietary levels up to 0.6% (Bird et al., 1986; Lington et al, 1997) . Increased kidney weights were observed in the subchronic and chronic studies. In the 13-week study conducted at dietary levels up to 2.0%, slight to moderate nephrosis with minimal to moderate granular tubular casts and an increased tubular regeneration were found in male rats at dietary levels greater than 0.3%. At a level of 0.3%, 4 of 13 males had minimal nephrosis without the granular tubular casts. There were some changes in urinalysis parameters of male rats (i.e., decrease in osmolality and increases in volume, glucose, protein, and renal epithelial cell counts) (Bird et al., 1986; EPL, 1982) . At the 6-, 12-, and 18-month sacrifices in the chronic study, chronic progressive nephropathy (CPN) was observed in the kidneys of treated rats. The CPN was accompanied by increased renal epithelial cells in the urine, along with a minimal increase in tubular cell pigment in the tubular epithelium of high-treatment level male rats. There were some slight effects on urinalysis parameters in the mid-and hightreatment level rats only at the 6-month sacrifice (Hazleton Laboratories, 1984a; 1984b; 1985) . Kidney sections from all serial sacrifices consistently revealed CPN, which was observed in nearly all (99%) of the rats at 24 months, but which was not increased in severity by treatment dose. CPN was usually more severe in male rats. At the terminal (24-month) sacrifice, there was a treatment-related increase in relative kidney weight, but there were no significant pathological changes observed in the kidneys (Lington, et al, 1997; Hazleton Laboratories, 1986) , perhaps because of the confounding high incidence of the spontaneously occurring CPN in aged rats (Peter, et al., 1986) . Renal neoplasms which were present in 3 (of 50) mid-dose and 2 (of 51) high-dose male rats consisted of 2 tumor types: transitional cell carcinomas arising from the urothelium (3 mid-treatment level males) and tubular cell carcinomas of renal tubule origin (2 high-treatment level males). According to the NTP guidelines (McConnell, et al., 1986 , NTP, 1984 , these histogenic types should not be combined for carcinogenic evaluation. Incidence of each of these tumor types was statistically non-significant when compared to control animals (Lington, et al, 1997) .
More recent chronic studies have reported kidney tumors in male rats that were administered DINP in the diet at 0.6% (i.e., 1 transitional cell carcinoma) and 1.2% (i.e., 2 tubular cell carcinomas, plus 4 tubular cell carcinomas in a separate 1.2% recovery group). However, kidney tumors were not observed in female rats (Butala et al, 1996 , manuscript in preparation) nor mice of either sex administered 0.8% in the diet (Butala et al, 1997) . Because these kidney tumors occurred only in male rats, and only at higher treatment levels than previously used, there was reason to suspect that the kidney tumor response was a sex-and species-specific effect resulting from induced cell proliferation secondary to alpha 2u-globulin (␣2UG) nephropathy. Technological advances in the fields of pathology and immunology, made since the time of the original chronic study (i.e., the early 1980s), permitted a retrospective investigation of the archived kidney specimens from the previous study. Thus, the purpose of the current study was to conduct a retrospective analysis of ␣2UG, cell proliferation and histopathology findings to determine whether the kidney effects observed in the previously reported chronic study (Lington et al, 1997) were a consequence of the ␣2UG male rat-specific nephropathy (e.g., Baetcke, 1991; IARC, 1998) .
MATERIALS AND METHODS
Test material and treatment. In the chronic study reported by Lington et al. (1997) , DINP (CAS No. 68515-48 -0) was supplied by Exxon Chemical Company, (Baton Rouge, LA). The purity was greater than 99% DINP as determined by high-pressure liquid chromatography (HPLC) analysis. Groups of 110 Fischer-344 rats/sex were fed diisononyl phthalate (DINP) at dietary levels of 0, 0.03, 0.3, and 0.6 wt% for periods up to 2 years. The mean daily intake of DINP for male rats (measured over 2 years) was 15, 152, and 307 mg/kg/day. Interim sacrifices of 10 pre-designated rats/sex/dose were at 6, 12, and 18 months with surviving animals sacrificed at 24 months. All aspects of the tasks associated with this study were conducted in compliance with Good Laboratory Practices according to EPA and OECD guidelines.
Experimental design. The present study used kidneys archived from the Lington et al. (1997) study that had been fixed in formalin, imbedded in paraffin, and stored for 14 years. The present study used a limited number of archived kidneys from the 6-and 12-month interim sacrifices to determine their suitability for the immunohistochemical (IHC) staining techniques used to measure ␣2UG and PCNA, and to evaluate the feasibility of using the Bioquant image-analysis system to objectively quantify these findings. A review of the literature indicated that archived tissues had been successfully used for PCNA analysis; however, no such reports of retrospective ␣2UG staining were located, nor were there reports on tissues archived for such an extended period. Following the feasibility study, all of the male rat kidneys, and the control and high-dose female rat kidneys from the 12-month interim sacrifice were evaluated for ␣2UG, PCNA, and histopathologic changes.
Tissue preparation. Serial sections of paraffin-embedded kidney tissues were cut at 5 m and placed on positively charged slides (Superfrost Plus, Fisher Scientific, Pittsburgh, PA) to ensure adhesion during processing for either ␣2UG or PCNA. Standard IHC methods were used to stain tissues for ␣2UG (Short et al., 1989) or PCNA (Eldridge et al., 1993 ) using a Sequenza Staining System (Shandon). Briefly, tissue sections were incubated with a monoclonal antibody to either ␣2UG (the antibody was a gift from the Chemical Industry Institute of Toxicology, Research Triangle Park, NC) or PCNA (PC10; Dako Corporation, Carpinteria, CA) and reagents required for the avidin-biotin peroxidase (Vectastain ABC peroxidase kit, Burlingame, CA) method for the detection of the antigen-antibody complex. Both ␣2UG accumulation and PCNA expression were localized by the chromagen 3,3Ј-diaminobenzidine tetrahydrochloride (DAB; Sigma Chemical Co.).
Alpha 2u-globulin determinations.
In the feasibility study, positive staining for ␣2UG was graded on a subjective severity scale of 0 to 4 (0 ϭ none, 1 ϭ minimal, 2 ϭ mild, 3 ϭ moderate, and 4 ϭ marked), according to size, staining intensity, and the extent of tubules loaded with ␣2UG. These subjective scores were compared to the objective scores of ␣2UG accumulation as measured with the Bioquant system in order to verify the Bioquant measurements. The Bioquant system was subsequently used to evaluate the ␣2UG accumulation in all of the kidney specimens.
Within an equally sized area, 3 parameters were measured in the kidney from each male rat: (1) the percentage of the area staining positive for ␣2UG was determined; (2) the number of ␣2UG-stained droplets was counted; (3) the size of the ␣2UG-stained droplets was determined. These computer-generated measurements were made in 3 fields per animal and the means were calculated.
Cell proliferation measurements. Positive staining for PCNA was categorized based on cellular distribution and intensity of the brown reaction product that correlated with the different phases of the cell cycle, as reported by Foley et al. (1991) . Uniform, dark brown nuclear staining was judged positive for S-phase cells. A cell in the G1-phase of the cell cycle had diffuse, stippled nuclear staining that was lighter than a cell in S-phase. Cells in the G2-phase exhibited distinct, diffuse cytoplasmic stippling with or without nuclear staining. Mitotic figures were conspicuous with diffuse cytoplasmic stippling. A labeling index (LI) was determined for each phase of the cell cycle in PCNA-stained kidneys. In addition, a proliferating index (PI) (PI ϭ G1 ϩ S ϩ G2 ϩ M-phases combined) was determined for PCNA-stained tissues. At least 2000 proximal tubular epithelial cells were scored in 10 randomly selected cortical fields.
Histopathology evaluations.
H and E-stained kidney tissues were examined for histomorphologic changes associated with chemically induced renal toxicity.
Statistical analysis. The ␣2UG data were analyzed by a one-way analysis of variance (Snedecor and Cochran, 1989) . If the analysis indicated significant differences, the treated means were compared to control by Dunnitt's test at the 5% and 1% levels of significance (Dunnett, 1964) . Residuals from the model were tested for normality by the Shapiro-Wilk statistic (Shapiro and Wilk, 1965) . The area and size variables were transformed by the square root transformation and the number scored was transformed by the 4th root transformation to achieve a normal distribution of the residuals.
RESULTS
Preliminary results showed positive staining for ␣2UG and PCNA in all six of the archived kidneys from male rats that were evaluated to determine the feasibility of the IHC techniques. Accumulation of ␣2UG did not appear to be increased in the high-treatment-level male rats at 6 months, whereas at 12 months, accumulation of ␣2UG was conspicuously greater in these rats than the concurrent controls. Based on the results and success of the preliminary study, the kidneys from the 12-month interim sacrifice were evaluated.
Group mean values and standard errors of the individual measurements of ␣2UG accumulation and cell proliferation, and the qualitative histopathology severity scoring of male and female rat kidneys are summarized in Table 1 . Only control and high-treatment group female rat kidneys were evaluated.
As indicated in Table 1 , ␣2UG was present in every male rat kidney examined. The severity of accumulation of ␣2UG in male rat kidneys, evaluated as mean % of area staining positive and mean size of droplets, was significantly increased (p Ͻ 0.05) in the 0.6% high-dose treatment group animals compared to controls but not in the 0.03% low-dose or 0.3% mid-dose treatment groups. The mean % of area staining positive was significantly decreased in the 0.03% low-treatment group animals compared to controls. Figure 1 presents photomicrographs demonstrating the increased accumulation and increased size of droplets staining positive for ␣2UG in kidney sections from a high-dose treatment group male rat (Fig. 1A) compared to a control male rat (Fig. 1B) . Overall cell proliferation did not appear to be increased in high-dose group males compared to controls; however, foci of excessive proliferating cells were frequently observed in the renal cortex of high-dose group male rats. Figure 2 presents photomicrographs showing cells staining positive for PCNA in kidney sections from a high-treatment group male rat ( Fig. 2A) compared to a control male rat (Fig. 2B) . These foci of proliferating cells, as well as the excessive ␣2UG accumulation shown in Figure 1 , occurred primarily in proximal tubule cells of the P2 segment, but were also seen in the P1 and P3 cells. The proliferating index (PI) for the high-dose level male animals was higher than the PI for controls, while the PI for the low-and mid-treatment level males were below that of controls. However, there was no apparent shift in the percent of cells staining positive for each phase of the cell cycle. Histopathologic examination of the male rat kidneys revealed treatment-related changes consistent with ␣2UG nephropathy. These included tubular regeneration in 35 of 39 kidneys of male rats, and tubular epithelial hypertrophy in 19 of 20 mid-and high-treatment group male rats. There was no tubular epithelial hypertrophy in control or low-treatment group male rats. ␣2UG was not detected in any of the female rat kidneys (Table 1) . Renal cell proliferation, as determined by PCNA expression, did not differ between control and high-treatment group female rats. There was minimal tubular regeneration in one of ten high-treatment level female rats; however, there was no indication of renal tubular epithelial hypertrophy in any of the female rats.
DISCUSSION
In this paper, we provide data that demonstrate that exposure to DINP results in ␣2UG accumulation in kidneys of male rats only, with an apparent threshold for effect, and conclude a male rat-specific mechanism is responsible for kidney tumors observed at high doses of DINP. These kidney tumors are likely caused by increased cell proliferation in response to kidney tissue damaged by the accumulation of ␣2UG. These findings are significant because the ␣2UG found in urine is produced in the liver by male rats only, whereas the electrophoretically-distinct forms of ␣2UG produced in extra-hepatic sites (salivary and preputial glands, among others) are not male rat-specific. For this reason, the nephropathy occurs only in male rats Swenberg and Lehman-McKeeman, 1998) . Since humans do not produce ␣2UG, Note. % Area, percentage of field staining positive for alpha 2U-globulin; mean of 3 fields. Number scored, number of individual droplets staining positive for alpha 2U-globulin; mean of 3 fields. Size, average size of the total number of ␣2UG droplets scored, determined by Bioquant image analysis system; mean of 3 fields.
ND ϭ none detected.
FIG. 1.
Photomicrograph of ␣2UG accumulation in male rat kidney showing the increased size and number of droplets staining positive in a kidney section from a high dose male rat (Fig. 1A) compared to a control male rat (Fig. 1B) . (Fig. 2A) . A kidney section from a control male rat is presented for comparison (Fig. 2B) . these male rat kidney tumors are not relevant to human risk assessment of DINP.
Typical lesions observed in ␣2UG nephropathy include single-cell necrosis, exfoliation of epithelial cells into proximal tubular lumen, formation of granular casts, linear mineralization of papillary tubules, and tubule hyperplasia (cell proliferation). If the response is mild, not all of these lesions may be observed; however, more sensitive detection techniques (e.g., immunohistochemical localization of proliferating cells) may be used in conjunction with histopathologic evaluation to demonstrate the pathological sequence of renal tubule tumors. Mechanistic studies with model compounds (e.g., d-limonene, unleaded gasoline) have demonstrated that the rate-limiting step in the development of the nephropathy is the ability of a chemical or its metabolites to bind reversibly, but specifically, to ␣2UG. Increased cell turnover and sustained cell proliferation are prerequisite to, and ultimately involved in, the tumor development associated with this syndrome. The accumulation of ␣2UG is known to have the potential to cause a rapid increase in cell division in the kidneys.
In the present study, ␣2UG accumulation was increased above control levels only in the high-dose group males (Table  1) . We also showed an increase in cell proliferation in those regions of the male rat kidneys that had increased ␣2UG accumulation by confirming the presence of PCNA, a protein associated with cell replication. In the present study, the extent and severity of ␣2UG accumulation paralleled the extent and localization of cell division in proximal tubule cells. Although the increases in both parameters were relatively small in highdose male rats compared to controls, qualitatively, the accumulation of ␣2UG and foci of excessive proliferating cells, particularly in renal cells in the P2 segment, are consistent with an ␣2UG-associated nephrotoxicity mechanism of action. Review of newly cut and H and E-stained sections revealed tubular epithelial hypertrophy and regeneration, consistent with the IHC findings. These findings are significant because the ␣2UG mechanism is recognized by USEPA (Baetcke et al., 1991) and IARC (1998) as a sex-and species-specific effect and not a risk factor for humans.
Conversely, decreased cell proliferation (decreased PI) was associated with decreased accumulation of ␣2UG in the animals exposed to lower doses of DINP. DINP has been shown to be a peroxisome-proliferating agent (Butala et al., 1996; Lington et al., 1997) . Thus, the current finding is consistent with a decreased liver production of ␣2UG, which has been reported in rats exposed to the peroxisome-proliferating agent, ciprofibrate (Alvares et al., 1996) , and has been attributed to down-regulation of the gene expressing ␣2UG (Lapinskas and Corton, 1997) . However, no data are available on the response of ␣2UG regulation at various doses of ciprofibrate or other peroxisome proliferating agents.
Chemically induced tumor responses can be species-, gender-, and tissue-specific, which suggests that some types of tumorigenic mechanisms may be unique to the rodent and potentially not applicable to human beings (Vainio et al., 1992) . One example is kidney tumorigenesis in the male F-344 rat. The male rat is highly susceptible to chemically induced renal tumor formation (particularly by nongenotoxic carcinogens) associated with ␣2UG (Borghoff et al.,1990; Dietrich and Swenberg, 1991; Flamm and Lehman-McKeeman, 1991) . The ␣2UG mechanism of action is specific to the male rat and does not appear to be operational in people. Thus, the EPA has accepted the recommendation of an EPA Technical Panel and the EPA Science Advisory Board not to use male rat kidney tumors associated with the ␣2UG nephropathy for human risk assessment (Baetcke et al., 1991) . IARC has recently adopted similar, but more stringent, criteria (IARC 1998) . To assist in interpretation of the current findings, the EPA and IARC criteria and experimental results for DINP are presented in Table 2 .
Although articulated differently, the criteria specified by IARC and EPA that must be met to demonstrate the ␣2UG mechanism are similar. However, in addition to the EPA criteria, IARC requires proof that the chemical or metabolite reversibly binds to ␣2UG in order to unequivocally demonstrate the ␣2UG mechanism. The findings reported here and in previous studies with DINP show that, except for a demonstration of reversible binding of DINP or a metabolite to ␣2UG, all criteria shown in Table 2 have been met. Thus, the evidence indicates that male rat-specific kidney tumors resulting from high dietary doses of DINP are likely due to ␣2UG-mediated effects and are not relevant to humans. The findings reported in the current study are consistent with the hypothesis that chronic dietary exposure to high levels of DINP can induce male rat-specific ␣2UG nephropathy that may progress to renal cancers. The renal tumors observed in the recent (Butala et al. 1996 (Butala et al. , 1997 ) studies of DINP were both species-and sexspecific and support this conclusion. (Baetcke et al., 1991) b Includes 13-week subchronic study and two2-year chronic studies conducted in F-344 rats and one chronic mouse study.
c Binding studies not specifically required by EPA.
The non-neoplastic kidney effects observed in female rats (Butala et al., 1996; Lington et al., 1997) and mice of both sexes (Butala et al., 1997) may be attributable to an exacerbation of chronic progressive nephropathy. Chronic progressive nephropathy is a spontaneous disease of unknown etiology common in aged rodents and may be a secondary effect related to peroxisomal proliferation since the rodent kidney contains significant levels of PPAR␣ (Ward et al., 1998) . Palmer et al. (1998) have shown that PPAR␣ levels in humans are less than 5% of the levels in mice. Thus, while these minimal kidney findings in rodents may be considered treatment-related effects (in high-dose animals), they are of little, if any, toxicological relevance to humans. Furthermore, these kidney effects were reversible as demonstrated by the lack of similar findings in the recovery group animals (Butala et al., 1996 (Butala et al., , 1997 . Woodward (1990, p. 400) reviewed the evidence linking phthalate treatment to kidney effects in animals as well as the development of cystic kidneys in humans, and concluded there is no basis for a cause and effect relationship, and " . . . the limited data available seem to suggest that humans are not susceptible to the cystogenic effects of phthalates, at least at the levels of 'normal' exposure. More animal studies would be highly desirable for reassurance." Results of the current studies on DINP, as well as other recent information on peroxisomal proliferation, provide a cohesive link that strongly indicate that rodent kidney effects of phthalate esters are not predictive of potential effects in humans.
In summary, application of immunohistochemical staining and computerized image analysis techniques to kidney samples archived for 14 years verified the accumulation of ␣2UG only in the kidneys of male rats treated at high (0.6%) dietary doses of DINP. The extent and severity of ␣2UG accumulation paralleled the extent and localization of cell proliferation in proximal tubule cells, as determined by the presence of PCNA. H and E-stained sections of male rat kidneys revealed tubular epithelial hypertrophy and regeneration, consistent with the IHC results. While not conclusive, due to lack of alpha 2u-globulin-binding studies as required by IARC, our findings are consistent with established criteria for demonstrating these kidney tumors are likely to be a male rat-specific response. Thus, it is unlikely that the renal tumors observed following DINP treatment are predictive of a human cancer risk. We also demonstrated that 14-year-old formalin fixed, paraffin-embedded tissue samples can be successfully immunohistochemically stained for ␣2UG and PCNA.
